Stay updated on Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision indicator on the page was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-09-01T19:32:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.4 to v3.6.5, indicating a platform update. The study details and user-facing content remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-11T14:50:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.3 to v3.6.4, indicating a deployment of a new build. The underlying study information and content remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-28T05:57:30.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The revision label in the page footer was updated from v3.6.2 to v3.6.3, signaling a minor maintenance update to the site.
    Difference
    0.1%
    Check dated 2026-07-06T15:48:44.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Page footer revision label updated from v3.6.0 to v3.6.2, indicating a minor platform update to the study details page. This change does not affect the study content or data displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-29T08:53:15.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page adds recruitment status information and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) while standardizing the Intervention/Treatment label and updating the revision tag to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:31:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page.